KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Receivables (2016 - 2025)

LifeMD (LFMD) has disclosed Change in Receivables for 14 consecutive years, with $459227.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 162.48% year-over-year to $459227.0, compared with a TTM value of -$1.2 million through Dec 2025, down 125.64%, and an annual FY2025 reading of -$1.2 million, down 125.64% over the prior year.
  • Change in Receivables was $459227.0 for Q4 2025 at LifeMD, up from -$95817.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $4.8 million in Q3 2024 and bottomed at -$2.0 million in Q2 2025.
  • Average Change in Receivables over 5 years is $397734.8, with a median of $420189.5 recorded in 2021.
  • The sharpest move saw Change in Receivables surged 2962.51% in 2023, then tumbled 697.92% in 2025.
  • Year by year, Change in Receivables stood at -$986755.0 in 2021, then surged by 164.33% to $634825.0 in 2022, then skyrocketed by 35.26% to $858668.0 in 2023, then tumbled by 185.6% to -$734988.0 in 2024, then skyrocketed by 162.48% to $459227.0 in 2025.
  • Business Quant data shows Change in Receivables for LFMD at $459227.0 in Q4 2025, -$95817.0 in Q3 2025, and -$2.0 million in Q2 2025.